Live feed
Filing
SC 13D
SC 13D0001104659-22-122435·Acrivon Therapeutics, Inc.
Schedule 13D ownership disclosure
ACRIVON THERAPEUTICS INC
Security class unavailable · CUSIP: 004890109
Event date: 2022-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,813,442
- Percent of class
- 23.0700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-122435
- Form type
- SC 13D
- Filer
- Acrivon Therapeutics, Inc.
- CIK
- CIK 1781174
- Filed
- Nov 28, 2022
- Reporting period
- Nov 17, 2022
- Description
- Schedule 13D beneficial ownership